Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Streptokinase-induced jaundice].

J A Gómez Guindal1, I Roldán Rabadán, J Perea Egido

  • 1Unidad Coronaria, Hospital Universitario La Paz, Madrid.

Revista Espanola De Cardiologia
|December 28, 1999
PubMed
Summary

This study reports a rare case of jaundice in a patient treated with streptokinase for acute myocardial infarction. The condition resolved within eight days, highlighting a potential, infrequent side effect of this common thrombolytic therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thoracolumbar fractures without neurological impairment: A review of diagnosis and treatment.

EFORT open reviews·2017
Same author

Do surgical expectations change depending on first time surgery or reoperation? A prospective cohort study in lumbar spine surgery.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2015
Same author

Cervical spine epithelioid hemangioendothelioma: case report.

European review for medical and pharmacological sciences·2014
Same author

[Unstable angina in the elderly: clinical, profile, management and mortality at three months. The PEPA Registry Data].

Revista espanola de cardiologia·2001
Same author

[Fixed-dose combination therapy: reduction of side effects with enhanced tolerance and antihypertensive efficacy].

Revista espanola de cardiologia·1999
Same author

[The clinical management guidelines of the Sociedad Española de Cardiología. Nuclear cardiology: the technical bases and clinical applications].

Revista espanola de cardiologia·1999

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Streptokinase is a widely used thrombolytic agent for acute myocardial infarction (AMI).
  • Early reperfusion therapy is crucial in managing AMI.
  • Systemic administration of streptokinase is a common treatment modality.

Observation:

  • A 35-year-old male presented with inferior AMI and received systemic streptokinase.
  • Six hours post-treatment, the patient developed fever, hepatomegaly, jaundice, and dark urine.
  • Laboratory tests revealed leukocytosis and elevated bilirubin levels.

Findings:

  • The patient's symptoms, including jaundice, indicated a potential adverse reaction to streptokinase.
  • Liver function tests showed transient enzymatic elevation and hyperbilirubinemia.
  • The condition showed progressive improvement, with complete symptom resolution by day eight.

Related Experiment Videos

Implications:

  • This case underscores the rare occurrence of jaundice as a secondary effect of streptokinase.
  • Awareness of this potential adverse event is important for clinicians managing AMI patients.
  • Further investigation into the mechanisms of streptokinase-induced hepatotoxicity may be warranted.